欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球疤痕治疗市场报告(2015-2019年)

Global Scar Treatment Market 2015-2019

加工时间:2015-02-22 信息来源:EMIS 索取原文[94 页]
关键词:疤痕;纤维组织;永久补丁;侵入性;非侵入性技术;外科手术;OTC
摘 要:Scars are permanent patches of fibrous tissue that result from the healing process of a wound and can be treated using invasive and non-invasive techniques, including surgery and OTC treatment products. These products and procedures can be used to treat all types of scars, such as keloid scars, contracture scars, hypertrophic scars, and atrophic scars. Scars caused by surgery can be removed by surgical revisions, although most people are reluctant to go for another invasive procedure after a surgery. Apart from the easily available OTC scar treatment products, patients can also go for lesser known alternatives such as cryotherapy, clinical peel, and compression.
目 录:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

07. Global Scar Treatment Market

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Market Segmentation by Application

08.1 Segmentation of Global Scar Treatment Market

by Application

08.1.1 Burn Scars

08.1.2 Post-surgical Scars Other than Burn Scars

08.1.3 Others

09. Market Segmentation by Type of Treatment

09.1 Segmentation of Global Scar Treatment Market

by Type of Treatment

09.2 OTC Scar Treatment Products

09.3 Alternative Treatment Methods

09.3.1 Dressings and Compression Treatment

09.3.2 Massage Treatment

09.3.3 Laser Treatment and Radiotherapy

09.3.4 Corticosteroid Treatment

09.3.5 Cryotherapy

09.3.6 Surgical Revision

10. Geographical Segmentation

10.1 Segmentation of Global Scar Treatment Market

by Geography 2014-2019

10.2 Scar Treatment Market in Europe

10.2.1 Market Size and Forecast

10.3 Scar Treatment Market in US

10.3.1 Market Size and Forecast

10.4 Scar Treatment Market in ROW

10.4.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.2 Major Vendors 2014

18.2.1 Key News

18.3 Other Prominent Vendors

18.4 Product Portfolio: Other Prominent Vendors

19. Key Vendor Analysis

19.1 Avita Medical

19.1.1 Key Facts

19.1.2 Business Overview

19.1.3 Business Segmentation by Revenue 2014

19.1.4 Business Segmentation by Revenue 2013 and 2014

19.1.5 Geographical Segmentation by Revenue 2014

19.1.6 Business Strategy

19.1.7 Recent Developments

19.1.8 SWOT Analysis

19.2 CCA Industries

19.2.1 Key Facts

19.2.2 Business Overview

19.2.3 Product Segmentation by Revenue 2013

19.2.4 Product Segmentation by Revenue 2012 and 2013

19.2.5 Geographical Segmentation by Revenue 2013

19.2.6 Business Strategy

19.2.7 Recent Developments

19.2.8 SWOT Analysis

19.3 Enaltus

19.3.1 Key Facts

19.3.2 Business Overview

19.3.3 SWOT Analysis

19.4 Merz Pharma

19.4.1 Key Facts

19.4.2 Business Overview

19.4.3 Subsidiaries

19.4.4 Key Products

19.4.5 Therapeutic Areas

19.4.6 Geographical Presence

19.4.7 Business Strategy

19.4.8 Recent Developments

19.4.9 SWOT Analysis

19.5 Oculus Innovative Sciences

19.5.1 Key Facts

19.5.2 Business Overview

19.5.3 Segmentation by Revenue 2014

19.5.4 Segmentation by Revenue 2013 and 2014

19.5.5 Geographical Segmentation by Product Revenue 2014

19.5.6 Business Strategy

19.5.7 Recent Developments

19.5.8 SWOT Analysis

19.6 Pacific World

19.6.1 Key Facts

19.6.2 Business Overview

19.6.3 Recent Developments

19.6.4 SWOT Analysis

19.7 Revitol

19.7.1 Key Facts

19.7.2 Business Overview

19.7.3 Product Segmentation

19.7.4 SWOT Analysis

19.8 Scarguard Labs

19.8.1 Key Facts

19.8.2 Business Overview

19.8.3 Key Products

19.8.4 SWOT Analysis

19.9 Suneva Medical

19.9.1 Key Facts

19.9.2 Business Overview

19.9.3 Key Offerings

19.9.4 Business Strategy

19.9.5 Recent Developments

19.9.6 SWOT Analysis

19.10 Valeant Pharmaceuticals International

19.10.1 Key Facts

19.10.2 Business Overview

19.10.3 Business Segmentation by Revenue 2013

19.10.4 Business Segmentation by Revenue 2012 and 2013

19.10.5 Sales by Geography

19.10.6 Business Strategy

19.10.7 Key Developments

19.10.8 SWOT Analysis

20. Other Reports in this Series

© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服